- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Tezacaftor + ivacaftor (&) ivacaftor – March 2019
Tezacaftor with Ivacaftor: Tablet containing tezacaftor 100 mg with ivacaftor 150 mg; Symdeko® (F508 deletion)
Last updated
5 July 2019